Effects of Dietary Supplement on Osteoarthritis

NCT03665116 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2023-07-14

No results posted yet for this study

Summary

This study evaluates the effects arginine on osteoarthritis (OA) in adults. Participants will be randomly divided into two groups, taking arginine and nothing, respectively. Outcomes will be evaluated by lab test results on OA joint cartilage and self-administered questionnaires. The hypothesis is that arginine can slow down or reverse OA.

Conditions

Interventions

DIETARY_SUPPLEMENT

L-arginine

L-arginine capsule

Sponsors & Collaborators

  • Ocean Frontier Institute

    collaborator UNKNOWN
  • Memorial University of Newfoundland

    lead OTHER

Principal Investigators

  • Guangju Zhai, PhD · Memorial University of Newfoundland

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2023-09-30
Completion
2024-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03665116 on ClinicalTrials.gov